Scott Shuda - 16 May 2025 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Director
Signature
/s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
Issuer symbol
INFU
Transactions as of
16 May 2025
Net transactions value
$0
Form type
4
Filing time
20 May 2025, 18:54:23 UTC
Previous filing
25 Apr 2025
Next filing
24 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shuda Scott Director C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS /s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda 20 May 2025 0001486636

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INFU Common Stock 101,994 16 May 2025 Direct
holding INFU Common Stock 298,383 16 May 2025 Footnote 1 F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFU Stock Option (right to buy) Award $0 +39,588 $0.000000 39,588 16 May 2025 Common Stock 39,588 $6.00 Direct F2
transaction INFU Stock Options (right to buy) Award $0 +11,876 $0.000000 11,876 16 May 2025 Common Stock 11,876 $6.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II ("BlueLIne"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine
F2 The option, representing the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026.
F3 The option, representing the right to purchase 11,876 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026.